Cargando…

BCL6 modulation of acute lymphoblastic leukemia response to chemotherapy

The bone marrow niche has a significant impact on acute lymphoblastic leukemia (ALL) cell phenotype. Of clinical relevance is the frequency with which quiescent leukemic cells, in this niche, survive treatment and contribute to relapse. This study suggests that marrow microenvironment regulation of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Slone, William L., Moses, Blake S., Hare, Ian, Evans, Rebecca, Piktel, Debbie, Gibson, Laura F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2016
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5029638/ https://www.ncbi.nlm.nih.gov/pubmed/27015556 http://dx.doi.org/10.18632/oncotarget.8273

Ejemplares similares

Rationale for targeting BCL6 in MLL-rearranged acute lymphoblastic leukemia
por: Hurtz, Christian, et al.
Publicado: (2019)

Pitavastatin Is Anti-Leukemic in a Bone Marrow Microenvironment Model of B-Lineage Acute Lymphoblastic Leukemia
por: Piktel, Debbie, et al.
Publicado: (2022)

Three-Dimensional Microfluidic Tri-Culture Model of the Bone Marrow Microenvironment for Study of Acute Lymphoblastic Leukemia
por: Bruce, Allison, et al.
Publicado: (2015)

Co-culture model of B-cell acute lymphoblastic leukemia recapitulates a transcription signature of chemotherapy-refractory minimal residual disease
por: Rellick, Stephanie L., et al.
Publicado: (2021)

Chemotherapeutic Activity of Pitavastatin in Vincristine Resistant B-Cell Acute Lymphoblastic Leukemia
por: Piktel, Debbie, et al.
Publicado: (2023)

Relapsed Acute Lymphoblastic Leukemia Presenting as Acute Renal Failure
por: Rose, Ashley, et al.
Publicado: (2019)

BCL6 inhibition ameliorates resistance to ruxolitinib in CRLF2-rearranged acute lymphoblastic leukemia
por: Tsuzuki, Shinobu, et al.
Publicado: (2022)

In Vitro Expansion of Bone Marrow Derived Mesenchymal Stem Cells Alters DNA Double Strand Break Repair of Etoposide Induced DNA Damage
por: Hare, Ian, et al.
Publicado: (2016)

Ikaros regulation of the BCL6/BACH2 axis and its clinical relevance in acute lymphoblastic leukemia
por: Ge, Zheng, et al.
Publicado: (2016)

Relationship between Bax and Bcl-2 Protein Expression and Outcome of Induction Phase Chemotherapy in Pediatric Acute Lymphoblastic Leukemia
por: Cahyadi, Andi, et al.
Publicado: (2022)

Towards personalized chemotherapy of acute lymphoblastic leukemia
por: Hnízda, Aleš, et al.
Publicado: (2018)

Comprehensive analysis of dose intensity of acute lymphoblastic leukemia chemotherapy
por: Karol, Seth E., et al.
Publicado: (2021)

RBP2 Promotes Adult Acute Lymphoblastic Leukemia by Upregulating BCL2
por: Wang, Xiaoming, et al.
Publicado: (2016)

BCL6 enables Ph(+) acute lymphoblastic leukemia cells to survive BCR-ABL1 kinase inhibition
por: Duy, Cihangir, et al.
Publicado: (2011)

Therapeutic Targeting of MERTK and BCL-2 in T-Cell and Early T-Precursor Acute Lymphoblastic Leukemia
por: Summers, Ryan J., et al.
Publicado: (2022)

Neurotoxicity Associated with Treatment of Acute Lymphoblastic Leukemia Chemotherapy and Immunotherapy
por: Śliwa-Tytko, Patrycja, et al.
Publicado: (2022)

Chemotherapy-Induced Oxidative Stress in Pediatric Acute Lymphoblastic Leukemia
por: Chaudhary, Preety, et al.
Publicado: (2023)

Severe recurrent nocturnal hypoglycemia during chemotherapy with 6-mercaptopurine in a child with acute lymphoblastic leukemia
por: Cho, Eun Mi, et al.
Publicado: (2018)

The acute lymphoblastic leukemia prognostic scoring whether it is possible by BCL-2, BAX gene promoter genotyping
por: Moazami-Goudarzi, Mozhagan, et al.
Publicado: (2016)

De novo acute lymphoblastic leukemia-like disease of high grade B-cell lymphoma with MYC and BCL2 and/or BCL6 rearrangements: a case report and literature review
por: Uchida, Akiko, et al.
Publicado: (2017)

2448 The effect of allopurinol on pediatric patients undergoing maintenance chemotherapy for acute lymphoblastic leukemia or lymphoblastic lymphoma
por: Bhuiyan, Mariam M., et al.
Publicado: (2018)

PHF6 mutations in T-cell acute lymphoblastic leukemia
por: Van Vlierberghe, Pieter, et al.
Publicado: (2010)

AMD3100 sensitizes acute lymphoblastic leukemia cells to chemotherapy in vivo
por: Yu, M, et al.
Publicado: (2011)

Impact of genetic polymorphisms on chemotherapy toxicity in childhood acute lymphoblastic leukemia
por: Gervasini, Guillermo, et al.
Publicado: (2012)

Psychological Impact of Chemotherapy for Childhood Acute Lymphoblastic Leukemia on Patients and Their Parents
por: Sherief, Laila M., et al.
Publicado: (2015)

Encephalopathy and brain atrophy during induction chemotherapy in acute lymphoblastic leukemia
por: Li, Qiao‐Ru, et al.
Publicado: (2020)

Alterations in Bone Turnover during Chemotherapy in Children with Acute Lymphoblastic Leukemia
por: Gupta, Vineeta, et al.
Publicado: (2021)

The Effect of Chemotherapy Induction Therapy on the Pancreas in Patients with Acute Lymphoblastic Leukemia
por: Wondmeneh, Temesgen Gebeyehu, et al.
Publicado: (2022)

Oral manifestations resulting from chemotherapy in children with acute lymphoblastic leukemia
por: de Morais, Everton Freitas, et al.
Publicado: (2014)

Venetoclax for Children and Adolescents with Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma
por: Gibson, Amber, et al.
Publicado: (2021)

Ceramide synthase-6 confers resistance to chemotherapy by binding to CD95/Fas in T-cell acute lymphoblastic leukemia
por: Verlekar, Dattesh, et al.
Publicado: (2018)

Analysis of the expression pattern of the BCL11B gene and its relatives in patients with T-cell acute lymphoblastic leukemia
por: Huang, Xin, et al.
Publicado: (2010)

Enhanced levels of the apoptotic BAX/BCL-2 ratio in children with acute lymphoblastic leukemia and high-risk features
por: Kaparou, Maria, et al.
Publicado: (2013)

BIM mediates synergistic killing of B-cell acute lymphoblastic leukemia cells by BCL-2 and MEK inhibitors
por: Korfi, K, et al.
Publicado: (2016)

Targeting Apoptosis Pathways With BCL2 and MDM2 Inhibitors in Adult B-cell Acute Lymphoblastic Leukemia
por: Hohtari, Helena, et al.
Publicado: (2022)

The oncogenetic landscape and clinical impact of BCL11B alterations in adult and pediatric T-cell acute lymphoblastic leukemia
por: Dourthe, Marie Emilie, et al.
Publicado: (2023)

Acute lymphoblastic leukemia
por: Schrappe, Martin
Publicado: (2018)

MLL-Rearranged Acute Lymphoblastic Leukemias Activate BCL-2 through H3K79 Methylation and Are Sensitive to the BCL-2-Specific Antagonist ABT-199
por: Benito, Juliana M., et al.
Publicado: (2015)

Treatment of refractory/relapsed adult acute lymphoblastic leukemia with bortezomib-based chemotherapy
por: Zhao, Junmei, et al.
Publicado: (2015)

2699. Pneumococcal Vaccination During Chemotherapy in Children Treated for Acute Lymphoblastic Leukemia
por: Dorval, Sarah, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_qore23ah9b770sfmccugrdmvlr